Download Southeast Cancer Control Consortium, Inc

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Alliance A071401
Southeast Clinical Oncology Research Consortium, Inc.
Authorization (Permission) to Use or Disclose (Release)
Identifiable Health Information For Research
Participant’s Name: ____________________________________________________________
Birth Date: ____________________
1. What is the purpose of this form?
The Alliance is an organization that does research to learn about the causes of cancer, and how to
prevent and treat cancer. Researchers from the following group would like to use your health
information for research:
 Alliance for Clinical Trials in Oncology (Alliance)
This information may include data that identifies you. Please carefully review the information
below. If you agree that researchers can use your identifiable health information, you must sign
and date this form to give them your permission.
2. What health information do the researchers want to use?
The researchers want to copy and use the portions of your medical record that they will need for
their research. If you enter an Alliance coordinated research study, information that will be used
and/or released may include your complete medical record, and in particular, the following:
 The history and diagnosis of your disease
 Specific information about treatments you received
 Information about other medical conditions that may affect your treatment
 Medical data, including laboratory test results, tumor measurements, CT scans, MRIs,
X-rays, photographs of radiation therapy target areas, and pathology results
 Information on side effects (adverse events) you may experience, and how these were
treated
 Long-term information about your general health status and the status of your disease
 Tissue and/or blood samples, associated data related to the analysis of the samples
 Numbers or codes that may identify you, such as your Social Security Number and
medical record number.
You may request a blank copy of the Alliance data forms from __________________
________________________________ (SCOR Study Coordinator or Clinical Research
Professional) to learn what information will be shared.
3. Why do the researchers want my health information?
___________________________________________________________ (name of site) will
collect your health information and share it with Alliance if you enter this Alliance research
study, or to evaluate your eligibility for a study. The Alliance researchers will use your
information for the following cancer research study.
8/25/15
Page 1 of 4
Alliance A071401
Southeast Clinical Oncology Research Consortium, Inc.
Study Title and Purpose of Study:
Study Title for Study Participants:
A study looking at targeted therapy according to tumor markers for people with
meningiomas
Official Study Title for Internet Search on http://www.ClinicalTrials.gov:
Phase II Trial of SMO/AKT/NF2 Inhibitors in Progressive Meningiomas with SMO/AKT/NF2
Mutations
The purpose of this study is to test good and bad effects of these two different drugs against
meningioma tumors with altered genes. Today, treatment for meningioma is the same for all
patients, and is not based on tumor genetic testing. This study is trying to see if tumor genetic
testing would be helpful at guiding treatment in patients such as you. Researchers have looked at
the DNA material (genes) that can be affected in meningioma and have found several genes that
are altered, or mutated. These include the genes called SMO and NF2. When the SMO or NF2
genes are altered, it can cause a tumor to grow. There are medications that target these 2 genes.
The medication, vismodegib, blocks the SMO receptor. Vismodegib has already been FDAapproved to treat basal cell cancer, which is a type of skin cancer. Vismodegib could shrink your
cancer but it could also cause side effects. Researchers hope to learn if the study drug will shrink
the cancer by at least one-half compared to its present size. There will be about 28 people taking
part in this group.
The medication, GSK2256098, blocks FAK, and seems to work better in tumors that have NF2mutations. GSK2256098 has been tested in other cancers. Researchers hope to learn if the study
drug will shrink the cancer by at least one-half compared to its present size.
There will be about 28 people taking part in this group.
4. Who will be able to use my health information?
___________________________________________________________ (name of site) will use
your health information for research. As part of this research, they may give your information to
the following Groups taking part in the research. _____________________________________
(name of site) may also permit staff from these Groups to review your original records as
required by law for audit purposes.
Southeast Clinical Oncology Research Consortium, Inc. (SCOR) Administrative Office
Alliance for Clinical Trials in Oncology (Alliance)
National Cancer Institute (NCI) and its representatives
Food and Drug Administration (FDA)
Office for Human Research Protections (OHRP)
Institutional Review Board (IRB) at ____________ Hospital
Possible other federal or state government agencies
Central laboratories: Biorepository at Mayo Clinic in Rochester, MN and the Center for
Molecular Oncologic Pathology at Dana Farber Cancer Institute in Boston, MA
where tissue samples (blood, bone marrow etc.,) are reviewed.
8/25/15
Page 2 of 4
Alliance A071401
Southeast Clinical Oncology Research Consortium, Inc.
5. How will information about me be kept private?
Alliance will keep all identifiable health information confidential to the extent possible, even
though they and other federal research groups are not subject to the same federal privacy laws
governing clinical centers. Alliance will not release identifiable health information about you to
others except as authorized by this form, or required by law.
However, once your information is given to other organizations that are not required to follow
federal privacy laws, we cannot assure that the information will remain protected.
6. What happens if I do not sign this authorization form?
If you do not sign this authorization form, you will not be able to take part in a research study for
which you are being considered.
7. If I sign this form, will I automatically be entered into the research study?
No, you cannot be entered into any research study without further discussion and separate
consent. After discussion, you may decide to take part in the research study. At that time, you
will be asked to sign a separate research consent form.
8. What happens if I want to withdraw my authorization?
You can change your mind at any time and withdraw this authorization. This request for
withdrawal must be made in writing. Beginning on the date you withdraw your authorization, no
new identifiable health information will be used for research. However, researchers may
continue to use the health information that was provided before you withdrew your permission.
If you sign this form and enter the research study, but later change your mind and withdraw your
authorization, you will be removed from the research study at that time.
To withdraw your authorization, please contact the person below. [He/she] will make sure your
written request to withdraw your authorization is processed correctly.
Contact Person: ________________________________________________________________
Title: ____________________________________________________________
Address: ________________________________________________________________
Phone: _________________________________ Fax: ____________________
9. How long will this authorization last?
If you agree by signing this form that researchers can use your identifiable health information,
this authorization has no expiration date. However, as stated above, you can change your mind
and withdraw your permission at any time.
8/25/15
Page 3 of 4
Alliance A071401
Southeast Clinical Oncology Research Consortium, Inc.
10. What are my rights regarding my identifiable health information?
You have the right to refuse to sign this authorization form. You have the right to review and/or
copy records of your health information kept by _____________________________________
(name of site). You do not have the right to review and/or copy records kept by Alliance or
other researchers associated with the research study.
******************************************************************************
Signatures
You will be given a copy of this authorization upon request.
I agree that my identifiable health information may be used and disclosed for research purposes
described in this form.
Signature of Participant or Participant’s Legal Representative:
________________________________________________
Date: ________________
Printed Name of Participant: ______________________________________________________
Printed Name of Legal Representative (if any): _______________________________________
Representative’s Authority to Act for Participant: _____________________________________
Signature of Person Obtaining Authorization: ___________________________ Date: ________
Printed Name of Person Obtaining Authorization: _____________________________________
8/25/15
Page 4 of 4